loader
Delivery Location

Ivacaftor (VX-770) 200mg

CAS# 873054-44-5

Grade: HPLC-UV

SKU: ChemD-976-S1144-200mg-1x200-Milligram-873054-44-5

Price per Unit
Tooltip icon
Quantity
Document Links
SDS Document
Form
Not Specified
Density
-
Appearance & Physical State
-
Color
-
Odor
-
Melting Point
212-215
Boiling Point
-
Freezing Point
212-215
Molecular Weight
392.49
Flash Point
-
pH value
-

Have a question regarding this product?

Contact Us

Shop all of the products from this supplier?

View Supplier Storefront
Country of Manufacture
-
Refractive Index
-
LogP
5.6
Exact/Molecular Mass
392.20999276 g/mol
Molar mass
-
Concentration
-
Water Content
-
Acid Content
-
Viscosity
-
Cloud Point
-
Specific heat of liquid
-
Thermo Stability
-
Oxygen Stability
-
Water Stability
-
Vapor Pressure
-
Assay (Gas chromatography)
-
Molecular formula
C24H28N2O3
Soluble
low (<0.05 g/mL)
Max Handling Temp
-
Recommended Dosage
-

Ivacaftor (VX-770) 200mg for Sale Online

Selleck Chemicals LLC manufactures Ivacaftor (VX-770) 200mg, for sale through ChemDirect.
Selleck Chemicals LLC sells Ivacaftor (VX-770) 200mg with a product grade of HPLC-UV and percent purity of 97%. Ivacaftor (VX-770) 200mg is for sale online in 1x10 Milligram, 1x10 Millimeter, 1x200 Milligram, 1x50 Milligram, and 1x5 Milligram quantities. Ivacaftor (VX-770) 200mg has the molecular formula C24H28N2O3 and a chemical weight of 392.49. Ivacaftor (VX-770) 200mg is also called vx-770, kalydeco, ivacaftor (vx-770), n-(2\\, 4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1\\, 4-dihydroquinoline-3-carboxamide, vx 770, vx770, unii-1y740ill1z, chebi:66901, n-[2\\, 4-bis(tert-butyl)-5-hydroxyphenyl]-1\\, 4-dihydro-4-oxo-3-quinolinecarboxamide, 1y740ill1z, 3-quinolinecarboxamide\\, n-(2\\, 4-bis(1\\, 1-dimethylethyl)-5-hydroxyphenyl)-1\\ and 4-dihydro-4-oxo-. It's CAS (Chemical Abstracts Service) Registry Number is 873054-44-5.

Save time and money when you buy Ivacaftor (VX-770) 200mg online through ChemDirect.

About the Supplier

Selleck Chemicals LLC Selleck's Bioactive Compound Libraries consist of over 8,000 small molecules with validated biological and pharmacological activities. The safety and effectiveness of these molecules has been demonstrated through preclinical and clinical research and many of them are FDA-approved compounds.